Methodology · Trademark of Insightful Agents

BELFB · NASDAQ Bel Fuse Inc. | Electronic Components — Magnetics, Power, Connectors | Sector route: Standard (DCF + Buffett + peer) $283.60

Bottom Line

Quality business at 53× free cash flow.

Operating quality is real — 87/100 Occam Score, 110% FCF/Net Income conversion, manageable leverage. Price is the problem: our DCF at $143.78 and the third-party DCF at $57.50 against a market of $283.60. FCF yield 1.9% — below the 10-year Treasury.

Verdict SELL4 SELL · 0 BUY

Confidence High

Last Price $283.60

Intrinsic Value (Our DCF) $143.78

3rd-Party DCF Cross-check $57.50

Margin of Safety −49.3%

Action Window Q2 2026 print

01Cash Flow Reality

Operating CF vs. Free CF (TTM, $M)

FY 2024

TTM

FY 2025

Q1 2026A

Operating CF Free CF

Quietly excellent business. Price is rich. Operating cash flow of $79.9M on $675.5M revenue (11.8% margin); capex consumes only ~15% of OCF, leaving $67.9M of free cash flow. FCF/Net Income conversion runs at 110%. But at a $3.58B market cap, FCF yield of 1.9% sits below the 10-year Treasury — the market is paying for compounding the trailing cash flow does not yet support.

Forensic anchor FCF yield 1.9% vs. 10-year Treasury ~4%. The risk-free rate is paying more than Bel Fuse's cash flow does at this price. The 26.3% trailing revenue growth needs to be structural, not cyclical, to justify the multiple.

02Forensic Jury — Four Independent Analysts

Occam-the-Auditor SELL · Med

Books are clean — Occam Score 87, 110% FCF/Net Income conversion, manageable leverage. But FCF of $67.9M against $3.58B market cap is a 1.9% yield — a cyclical hardware company at 53× FCF. Good business at a bad price is still a bad investment.

Occam-the-Architect SELL · Med

Disclosure language shows no urgency or hedging typical of companies approaching cycle peaks — a complacency tell. Terminal value at 62.9% of EV leans hard on growth duration the prose never substantiates.

Occam-the-Storyteller SELL · High

Two professional DCFs at $143.78 and $57.50 — a 150% deviation. That isn't noise; it's a silent scream. The market values Bel Fuse on a narrative the snapshot does not contain. When the “why” is absent and the numbers say overvalued, the silence is the signal.

Occam-the-Sentinel SELL · Med

Cross-reference confirms no offsetting external catalyst: no analyst upgrades, no competitor moves, no contract disclosures. 52-week range $67.50–$291.77 shows the run-up is technical, not fundamental. RSI-14 at 70.7 (overbought).

Jury
Verdict 4 SELL · 0 BUY. All four lenses converge on overvaluation through different methods. Merged verdict SELL @ HIGH. Thesis lives or dies on whether 11.33% modeled growth proves structural rather than late-cycle.

Generated by Your Firm Name Here · Sources: SEC 10-K (FY2025), FMP fundamentals (TTM), Damodaran industry data, third-party DCF cross-check
For informational purposes only. Not investment advice. Consult your advisor before acting.

Page 01 / 02

Methodology · Trademark of Insightful Agents

03Forensic Scorecard — Industrial Hardware

Metric

Value

Signal

Note

Margin of Safety Our DCF vs market price

−49.3%

Red

$143.78 DCF vs $283.60 market — quality priced as compounder

FCF Yield (TTM) $67.9M FCF / $3.58B market cap

1.9%

Red

Below 10-year Treasury — cash flow doesn't pay you to wait

3rd-Party DCF Crosscheck Independent intrinsic value model

$57.50

Red

Implies −80% downside — 5× spread vs market

Reported P/E vs Sector P/E FMP TTM PE vs sector multiple

67.5 vs 72.2

Amber

Sector PE inflated by AI-adjacent hardware peers; not a real anchor

Rule of 40 (OCF-based) 26.3% growth + 11.8% OCF margin

38.1

Amber

Just below the 40 threshold — dependent on growth durability

Buffett Validation 7-metric financial-statement screen

5 / 7

Amber

Fails Cash > Debt ($57.8M vs $237.3M) and Net Margin >20% (9.1%)

Occam Forensic Score Quality, divergence, zombie checks

87 / 100

Green

Strong business mechanics; no manipulation or zombie flags

04Lens Findings — What Each Persona Caught

The Numbers (Auditor)

$67.9M FCF vs. $3.58B market cap = 1.9% FCF yield

Below the risk-free rate. A 53× FCF multiple is not a value-investor entry point.

Severity: high

26.3% trailing revenue growth used to anchor an 11.33% DCF growth rate

If growth is structural, defensible. If late-cycle or acquisition-driven, mean-reverts to 3–5% and intrinsic collapses toward the third-party DCF.

Severity: high

The Words (Architect)

terminal value accounts for 62.9% of enterprise value

Heavy reliance on growth duration; disclosure language doesn't substantiate it.

Severity: high

notable lack of urgent or hedging language typical of companies facing downturns

Confidence in the prose where the cycle would normally provoke caution — Architect's signature complacency tell.

Severity: medium

The Absences (Storyteller)

two professional DCFs at $143.78 and $57.50 — a 150% deviation

Two independently constructed models, one underlying business, no agreement — the silent scream.

Severity: high

no disclosed transformative product line, no contract win, no acquisition narrative bridging the valuation gap

Market is buying a story not in the snapshot. When the “why” is absent and the numbers say overvalued, that is the signal.

Severity: medium

05Risks & Kill Criteria

01DCF model divergenceHigh

Our DCF ($143.78) and the third-party DCF ($57.50) disagree by 2.5×, forming a 5× spread with the $283.60 market. Two cash-flow models cannot both be right; one is making materially wrong assumptions about growth duration or terminal economics.

02Growth-rate fragilityHigh

DCF anchors 11.33% growth. Trailing 26.3% revenue growth in cyclical hardware is rarely structural — if acquisition-driven or cycle-driven, mean reversion to 3–5% collapses intrinsic value toward the $57.50 third-party DCF.

03Cyclical leverage at peakMedium

$237M debt vs $57.8M cash — net debt $179.5M, manageable now. Net Debt / EBITDA ~1.6–1.8× becomes restrictive if revenue rolls over with the cycle.

Occam's Kill Criteria

Cash > Debt Fail (net debt $179.5M)

FCF yield > risk-free rate Fail (1.9% < ~4%)

Gross margin > 40% Pass (50%)

Net margin > 20% Fail (9.1%)

Capex margin < 25% Pass (1.8%)

Thesis-invalidating event None observed

Four-juror AI ensemble of independent leading-edge LLMs from different providers runs in parallel against the same SEC 10-K, FMP fundamentals, and Damodaran industry data. Consensus is weighted-mean — primary lenses (Auditor + Architect) carry more decision-weight than secondary lenses (Storyteller + Sentinel), with a FLAGGED override forcing FLAGGED on any single dissent. Cash-flow primacy: GAAP earnings cross-checked against operating cash flow and FCF yield.

Generated by Your Firm Name Here · 2026 · 05 · 03
For internal advisor use. Documents the analytical methodology applied; not a recommendation.

Page 02 / 02